Medicine for treating hypertensive encephalopathy

A technology for hypertension and encephalopathy, applied in the field of traditional Chinese medicine, can solve the problems of non-parallel cerebral edema and blood pressure, poor control of safe dose, blood perfusion disorder, etc., to prevent cardiac insufficiency, reduce the risk of secondary myocardial infarction, The effect of controlling epilepsy

Inactive Publication Date: 2013-04-03
范丰双
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

This patented method described in this patents allows us to treat diseases associated with abnormal regulations involving autonomic nervous systems (ANS) without causing damage themselves. It does this through combining different ingestible substances like rofax oil and shiny clay instead of traditional methods like quaternaries. By adding certain chemical agents called loofa wolfhair powders, we have improved efficacy against ANES compared to other therapies. Additionally, there may be side benefits from taking another pill containing licensed herb extractives alongside those taken separately. Overall, our technical results aimed at improving treatment options for neurologists who require them to manage their own body's regulatory functions over time due to changes made during disease progression.

Problems solved by technology

This patents discusses various treatments aimed towards reducing elevational congestion caused by high levels of serum lipids called trigemoryceramides ("TG"). These therapies involve administering specific types of medicines that target these substances specifically involved in their metabolism. Examples of existing methods mentioned in previous researchers' texts includes injecting anesthesia into the patient through vasodilators like hypotension, transplant surgery, administration of beta blocker agents, use of alpha adronexidase type 1 defibrators, calcium channel blocking agent, and other techniques involving slow release from controlled prescription drugs. Overall, all current approaches suffer drawbacks including lack efficacy due to side effects, difficulty in achieving complete remission without relapse after treatment, potential safety concerns associated with long term exposures, and poor management performance leading to frequent hospitalization.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0027] Example 1, raw material drug weight ratio: loofah 10g, earthworm 8g, sarcophagus 8g, aescin 6g, papaya 6g, pangolin 8g, tallow 6g, cassia twig 3g, stone gallbladder 3g.

Embodiment 2

[0028] Example 2, raw material drug weight ratio: loofah 20g, earthworm 15g, sarcophagus 15g, aescin 10g, papaya 10g, pangolin 15g, tallow 10g, cassia twig 6g, stone gallbladder 6g.

Embodiment 3

[0029] Example 3, raw material drug weight ratio: loofah 15g, earthworm 10g, sarcophagus 10g, aescin 8g, papaya 8g, pangolin 10g, tallow 8g, cassia twig 5g, stone gallbladder 5g.

[0030] When in use, add water to decoct the Chinese medicine loofah of the present invention, earthworm, sarcophagus, aescin, papaya, pangolin, tallow, stone gallbladder, cassia twig, merge the filtrate, and take it in the morning and evening. Or make dosage forms such as oral liquid and use.

[0031] The effective combination and coordination of the above drugs can effectively achieve the purpose of treating hypertensive encephalopathy with less side effects. The above results are fully proved by the clinical data, and the relevant data are as follows, wherein the drug used in the study is the weight ratio of the bulk drug in Example 3.

[0032] 1 Objects and methods.

[0033] 1.1 Objects: 42 patients with hypertensive encephalopathy diagnosed between January 2008 and September 2011. All patients met

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a medicine for treating hypertensive encephalopathy to solve the problem of treatment of hypertensive encephalopathy. The medicine is characterized by being prepared from the following raw materials in parts by weight: 10-20 parts of luffa vegetable sponge, 8-15 parts of earthworm, 8-15 parts of herba sarcandrae, 6-10 parts of paris polyphylla, 6-10 parts of pawpaw, 8-15 parts of pangolin scales, 6-10 parts of Chinese tallowtree root-bark, 3-6 parts of cassia twig and 3-6 parts of stone ball. Clinical experiments prove that the medicine has the characteristics of good curative effect on hypertensive encephalopathy and higher safety, and deserves clinical application and promotion.

Description

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Owner 范丰双
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap